Blood pressure drug may shield heart and kidneys after ICU kidney injury
NCT ID NCT05272878
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study tests whether a common blood pressure medication (angiotensin receptor blocker) can prevent serious heart problems and kidney decline in patients who had acute kidney injury while in the intensive care unit. About 508 adults aged 18–75 will receive either the drug or a placebo for one year after leaving the ICU. The goal is to see if the drug reduces the risk of heart failure, stroke, heart attack, and chronic kidney disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Lariboisière
Paris, 75010, France
Conditions
Explore the condition pages connected to this study.